550 related articles for article (PubMed ID: 15659147)
21. ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab.
Chikaraishi T; Sasaki H; Tsutsumi H; Miyano S; Nakazawa R; Nakano T; Kitajima K; Kudo H; Takahashi T; Sato Y; Kimura K
Transplant Proc; 2008 Dec; 40(10):3445-7. PubMed ID: 19100409
[TBL] [Abstract][Full Text] [Related]
22. The clinical application of monoclonal antibody therapies in renal transplantation.
Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD
Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134
[TBL] [Abstract][Full Text] [Related]
23. Early diagnosis and successful treatment of acute antibody-mediated rejection of a renal transplant.
Yang YW; Lin WC; Wu MS; Lee PH; Tsai MK
Exp Clin Transplant; 2008 Sep; 6(3):211-4. PubMed ID: 18954299
[TBL] [Abstract][Full Text] [Related]
24. Rituximab and intravenous immune globulin for desensitization during renal transplantation.
Vo AA; Lukovsky M; Toyoda M; Wang J; Reinsmoen NL; Lai CH; Peng A; Villicana R; Jordan SC
N Engl J Med; 2008 Jul; 359(3):242-51. PubMed ID: 18635429
[TBL] [Abstract][Full Text] [Related]
25. Acute cellular rejection.
Ganji MR; Broumand B
Iran J Kidney Dis; 2007 Oct; 1(2):54-6. PubMed ID: 19363277
[TBL] [Abstract][Full Text] [Related]
26. B cell monitoring of transplant patients treated with anti-CD20.
Abdallah KO; Prak ET
Clin Transpl; 2006; ():427-37. PubMed ID: 18365400
[TBL] [Abstract][Full Text] [Related]
27. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
28. Treatment of vascular rejection with rituximab in cardiac transplantation.
Garrett HE; Duvall-Seaman D; Helsley B; Groshart K
J Heart Lung Transplant; 2005 Sep; 24(9):1337-42. PubMed ID: 16143254
[TBL] [Abstract][Full Text] [Related]
29. [Antibody-mediated acute rejection].
Lefaucheur C; Nochy D; Glotz D
Nephrol Ther; 2008 Oct; 4 Suppl 3():S188-91. PubMed ID: 19000885
[TBL] [Abstract][Full Text] [Related]
30. The emerging role of rituximab in organ transplantation.
Becker YT; Samaniego-Picota M; Sollinger HW
Transpl Int; 2006 Aug; 19(8):621-8. PubMed ID: 16827678
[TBL] [Abstract][Full Text] [Related]
31. Refractory acute renal allograft rejection successfully treated with photopheresis.
Genberg H; Kumlien G; Shanwell A; Tydén G
Transplant Proc; 2005 Oct; 37(8):3288-9. PubMed ID: 16298575
[TBL] [Abstract][Full Text] [Related]
32. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
33. De novo production of donor-specific anti-HLA alloantibodies in early acute humoral renal allograft rejection.
Spriewald BM; Hugo C
Clin Transpl; 2006; ():469-72. PubMed ID: 18365405
[TBL] [Abstract][Full Text] [Related]
34. Early and late humoral rejection: a clinicopathologic entity in two times.
Péfaur J; Díaz P; Panace R; Salinas P; Fiabane A; Quinteros N; Chea R; Naranjo E; Wurgaft A; Beltran E; Elgueta S; Wegmann ME; Gajardo JG; Contreras L
Transplant Proc; 2008 Nov; 40(9):3229-36. PubMed ID: 19010241
[TBL] [Abstract][Full Text] [Related]
35. Does MICA influence acute rejection in kidney transplantation?
Kato M; Kinukawa T; Hattori R; Tsuji Y; Hirano A; Horie K; Tsuyuki M; Mizutani K
Clin Transpl; 2006; ():389-93. PubMed ID: 18365394
[TBL] [Abstract][Full Text] [Related]
36. The significance of the IgG anti-B-cell crossmatch on renal transplant outcome.
Ghasemian SR; Light JA; Currier CB; Sasaki T; Aquino A; Rees J; Ward W; Carr J
Clin Transplant; 1997 Oct; 11(5 Pt 2):485-7. PubMed ID: 9361946
[TBL] [Abstract][Full Text] [Related]
37. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
Schulz T; Papapostolou G; Schenker P; Kapischke M
Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
[TBL] [Abstract][Full Text] [Related]
38. Clinical impacts of CD38+ B cells on acute cellular rejection with CD20+ B cells in renal allograft.
Hwang HS; Song JH; Hyoung BJ; Lee SY; Jeon YJ; Kang SH; Chung BH; Choi BS; Choi YJ; Kim JI; Moon IS; Kim YS; Yang CW
Transplantation; 2010 Jun; 89(12):1489-95. PubMed ID: 20393401
[TBL] [Abstract][Full Text] [Related]
39. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation.
Sawada T; Fuchinoue S; Kawase T; Kubota K; Teraoka S
Clin Transplant; 2004 Jun; 18(3):254-60. PubMed ID: 15142045
[TBL] [Abstract][Full Text] [Related]
40. Successful therapy with rituximab of refractory acute humoral renal transplant rejection: a case report.
Celik A; Saglam F; Cavdar C; Sifil A; Atila K; Sarioglu S; Bora S; Gulay H; Camsari T
Transplant Proc; 2008; 40(1):302-4. PubMed ID: 18261611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
